Lihong Weng

5.1k total citations · 1 hit paper
50 papers, 2.4k citations indexed

About

Lihong Weng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lihong Weng has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Lihong Weng's work include CAR-T cell therapy research (23 papers), Immunotherapy and Immune Responses (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Lihong Weng is often cited by papers focused on CAR-T cell therapy research (23 papers), Immunotherapy and Immune Responses (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Lihong Weng collaborates with scholars based in China, United States and Switzerland. Lihong Weng's co-authors include Stephen J. Forman, Christine E. Brown, Behnam Badie, Julie R. Ostberg, Renate Starr, Michael E. Barish, Massimo D’Apuzzo, Jamie R. Wagner, Wen-Chung Chang and Michael C. Jensen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Lihong Weng

46 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

2015 592 citations Christine E. Brown, Behnam Badie et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Lihong Weng

Since Specialization

Citations

This map shows the geographic impact of Lihong Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Weng more than expected).

Fields of papers citing papers by Lihong Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihong Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Weng. The network helps show where Lihong Weng may publish in the future.

Co-authorship network of co-authors of Lihong Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Weng. A scholar is included among the top collaborators of Lihong Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Weng. Lihong Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The dual impact of oxidative stress on breast cancer 2025 ·Scientific Reports ·Jing‐Rong Li, Nanping Lin, Shengli Zhang, Chen Chen, Lihong Weng, Yingping Cao	0
2	Characterization of the tumor microenvironment in breast cancer brain metastasis 2024 ·Heliyon ·Jing‐Rong Li, Nanping Lin, (unknown), Lihong Weng, Chen Chen, (unknown), Yingping Cao	4
3	Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients 2024 ·Blood ·Juan Du, (unknown), Jing Lu, (unknown), Haiyan He, Jin Liu, (unknown), Ying Yang, Zhongyuan Feng, (unknown), Xiaoqiang Fan, Nina Shah, Qi Zhang, Jia Liu, Lihong Weng, Lianjun Shen, Wei Cao	0
4	Electrochemical immunoassay for gastric cancer biomarker pepsinogen I detection based on PdAgPt/MoS₂ 2024 ·Biomedical Materials ·Chunsheng He, (unknown), Xin Jin, Lihong Weng, Libin Chen, Lijuan Wang, Sicong Jiang, (unknown)	1
5	Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma 2022 ·Neoplasia ·Michael E. Barish, Lihong Weng, (unknown), Yubo Zhai, Renate Starr, Massimo D’Apuzzo, Russell C. Rockne, Haiqing Li, Behnam Badie, Stephen J. Forman, Christine E. Brown	11
6	A Scholarly Review of Supply Chain Integration within the New Zealand Blueberry Industry 2020 ·Massey Research Online (Massey University) ·C. N. Bezuidenhout, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lihong Weng, (unknown), (unknown), (unknown), Harpreet Kour, (unknown)	0
7	Lentiviral delivery of combinatorial CAR/CRISPRi circuit into human primary T cells is enhanced by TBK1/IKKɛ complex inhibitor BX795 2020 ·Journal of Translational Medicine ·Lingyu Li, Yuan Gao, Richa Srivastava, Wei Wang, Qinghui Xiong, (unknown), (unknown), (unknown), (unknown), (unknown), Zhifen Yang, Lihong Weng, Lei S. Qi, Francesco M. Marincola	14
8	Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma 2020 ·Frontiers in Oncology ·Yuan Zhang, Jianbo Chen, Yunan Zhao, Lihong Weng, Yiquan Xu	6
9	Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer 2019 ·Journal of Cancer Research and Clinical Oncology ·Yiquan Xu, Yina H. Huang, Lihong Weng, (unknown), Yi Huang, Ying Lin, Yunan Zhao, Hongru Li, (unknown)	8
10	A review on protective role of genistein against oxidative stress in diabetes and related complications 2019 ·Chemico-Biological Interactions ·Lihong Weng, Fengying Zhang, Rui Wang, (unknown), (unknown)	57
11	Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes 2018 ·EBioMedicine ·(unknown), Xiangyang Qin, Qunxing An, Jing Yi, Fan Feng, Dandan Yin, (unknown), Zheng Liu, Lihong Weng, (unknown), Xingbin Hu, Wen Yin	25
12	Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma 2017 ·Clinical Cancer Research ·Xiuli Wang, Miriam Walter, Ryan Urak, Lihong Weng, Christian Huynh, Laura Lim, ChingLam W. Wong, Wen-Chung Chang, Sandra H. Thomas, James F. Sanchez, Lu Yang, Christine E. Brown, Flavia Pichiorri, Myo Htut, Amrita Krishnan, Stephen J. Forman	149
13	Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer 2017 ·OncoImmunology ·Saul J. Priceman, Ethan Gerdts, Dileshni Tilakawardane, (unknown), John P. Murad, Anthony K. Park, Brook Jeang, Yukiko Yamaguchi, Xin Yang, Ryan Urak, Lihong Weng, Wen-Chung Chang, Sarah Wright, Sumanta K. Pal, Robert E. Reiter, Anna M. Wu, Christine E. Brown, Stephen J. Forman	120
14	Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma 2017 ·Molecular Therapy ·Christine E. Brown, Brenda Aguilar, Renate Starr, Xin Yang, Wen-Chung Chang, Lihong Weng, Brenda Chang, Aniee Sarkissian, Alfonso Brito, James F. Sanchez, Julie R. Ostberg, Massimo D’Apuzzo, Behnam Badie, Michael E. Barish, Stephen J. Forman	226
15	Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion 2017 ·Leukemia ·Bijender Kumar, Mayra García, Lihong Weng, Xiaoman Jung, Jodi Murakami, Xingbin Hu, Tinisha McDonald, Alex W. H. Lin, Ashish Kumar, David DiGiusto, Anthony S. Stein, Vinod Pullarkat, Susanta Hui, Nadia Carlesso, YH Kuo, Ravi Bhatia, Guido Marcucci, (unknown)	328
16	Identification of a CD133−CD55− population functions as a fetal common skeletal progenitor 2016 ·Scientific Reports ·Lihong Weng, Xingbin Hu, Bijender Kumar, Mayra García, Иван Тодоров, Xiaoman Jung, Guido Marcucci, Stephen J. Forman, Ching‐Cheng Chen	2
17	Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche 2016 ·Nature Communications ·Xingbin Hu, Mayra García, Lihong Weng, Xiaoman Jung, Jodi Murakami, Bijender Kumar, Charles Warden, Иван Тодоров, Ching‐Cheng Chen	50
18	Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma breakdown → 2015 ·Clinical Cancer Research ·Christine E. Brown, Behnam Badie, Michael E. Barish, Lihong Weng, Julie R. Ostberg, Wen-Chung Chang, Araceli Naranjo, Renate Starr, Jamie R. Wagner, Christine L. Wright, Yubo Zhai, James R. Bading, Julie A. Ressler, Jana Portnow, Massimo D’Apuzzo, Stephen J. Forman, Michael C. Jensen	592
19	RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma 2014 ·Cancer Research ·Xuebo Chen, Leying Zhang, (unknown), Junling Liang, Huaqing Wang, Mao Ouyang, Shihua Wu, Anna Carolina Carvalho da Fonseca, Lihong Weng, Yasuhiko Yamamoto, Hiroshi Yamamoto, Rama Natarajan, Behnam Badie	132
20	Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis 2012 ·PLoS ONE ·Xiwei Wu, Lihong Weng, Xuejun Li, Chao Guo, Sumanta K. Pal, Jennifer Jin, Yuping Li, Rebecca A. Nelson, Bing Mu, Susan Onami, Jeffrey Wu, Nora Ruel, Sharon P. Wilczynski, Hanlin Gao, Maricela Covarrubias, Robert A. Figlin, Lawrence M. Weiss, Huiqing Wu	151

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact